NIAGEN BIOSCIENCE, INC. Income (Loss) from Continuing Operations before Income Taxes, Domestic
NIAGEN BIOSCIENCE, INC. (NAGE) reported Income (Loss) from Continuing Operations before Income Taxes, Domestic of $18.22 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-04.
Financial Statements › Income Statement › Pre-tax Income
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic · last filed 2026-03-04
- NIAGEN BIOSCIENCE, INC. income (loss) from continuing operations before income taxes, domestic for fiscal 2025 was $18.22M, a 106.51% increase from fiscal 2024.
- NIAGEN BIOSCIENCE, INC. income (loss) from continuing operations before income taxes, domestic for fiscal 2024 was $8.82M.
| Period end | Income (Loss) from Continuing Operations before Income Taxes, Domestic 12 month |
|---|---|
| 2025-12-31 | $18.22M 10-K · filed 2026-03-04 |
| 2024-12-31 | $8.82M 10-K · filed 2026-03-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |